Skip to main content

Research Archives

All-in-one pill helps reduce blood pressure, cholesterol

Sep. 19, 2019—A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.

Read more


Genetics key to treating heart muscle disorders: Vanderbilt Prize lecturer

Sep. 19, 2019—Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.

Read more


Year two for Master’s Program in Biomedical Sciences

Sep. 9, 2019—Vanderbilt's Master’s Program in Biomedical Sciences prepares students for a broad array of health professional careers.

Read more


Team explores epilepsy-related brain disturbances

Sep. 5, 2019—A team led by a neurosurgeon-scientist and an engineering professor who specializes in techniques for analyzing functional neuroimaging data has received a $3 million grant to study disturbances in brain networks related to attention lapses and cognitive deficits in patients with temporal lobe epilepsy.

Read more


Zebrafish aid effort to regenerate damaged retinas

Sep. 5, 2019—According to a new study, the tiny zebrafish may hold the secret to regenerating damaged retinas in humans.

Read more


Novel treatment for Prader-Willi syndrome being tested at VUMC

Sep. 4, 2019—A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.

Read more


Partnership to help bring Zika virus therapy to clinic

Sep. 4, 2019—Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago.

Read more


Colorectal cancer researchers receive SPORE funding

Aug. 26, 2019—Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

Read more


Grant strengthens breast cancer research efforts

Aug. 22, 2019—Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

Read more


Discovery may point to better treatments for Type 1 diabetes

Aug. 22, 2019—Researchers have made a paradigm-shifting discovery that could lead to new treatments, better health and longer life for patients with Type 1 diabetes.

Read more


Potential second-line melanoma treatment identified

Aug. 15, 2019—A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

Read more


Protein’s role in inflammation-related cancer studied

Aug. 15, 2019—Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more